Angela Osborne

Angela has over 30 years’ experience in biopharmaceutical and cell and gene therapy businesses, processes and facilities. Angela works closely with clients to guide and support them through new product expansion projects, starting from the strategic business review, ensuring the early definition of technical requirements is focussed on the business benefits and that the final solution delivers these benefits.